Clinical trial Recruiting at 1 site Interventional Ages 65 and up

Perioperative transcranial photobiomodulation to see if it helps older adults recover brain function after surgery

Official title: Impact of Perioperative Transcranial Photobiomodulation on Delayed Neurocognitive Recovery in Older Patients After Surgery: a Randomized, Double-blind, Pseudo-modulation-controlled Preliminary Clinical Trial

Run by Peking University First Hospital · NCT07736092 · Data updated 2026-11-12

This trial tests whether applying light therapy to the brain around the time of surgery can reduce delayed brain recovery in older patients with pre-existing cognitive decline.

More Postoperative Delirium trials

Quick facts

Study typeInterventional
Ages65 Years and up
SexAll
Enrollment130 (estimated)
SponsorPeking University First Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedAugust 5, 2026
Main results expectedJuly 2027
Study endsJuly 2027
Registry record updatedAugust 10, 2026
Trial IDNCT07736092 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Older adults (65+) with preoperative MMSE < 27 undergoing non-cardiac, non-neurosurgical surgery with general anesthesia and a planned hospital stay.

Probably not a fit

Individuals without pre-existing cognitive impairment or those not meeting perioperative timing or safety criteria may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study investigates whether perioperative transcranial photobiomodulation can reduce delayed neurocognitive recovery and postoperative delirium in adults aged 65 and older with pre-existing cognitive impairment. Participants undergoing non-cardiac, non-neurosurgical procedures under general anesthesia will receive transcranial photobiomodulation or a sham/alternative method during the perioperative period. Primary outcome is delayed neurocognitive recovery, with postoperative delirium as a secondary endpoint. The approach builds on prior safety data and exploratory findings in other populations, aiming to improve postoperative brain outcomes in high-risk older adults.

Why it matters

Potential benefit: If successful, participants may experience better preservation of cognitive function after surgery and fewer delirium episodes.

How similar studies have gone: Previous small studies in other conditions suggest potential neurocognitive benefits from photobiomodulation, but evidence in perioperative delirium is limited and somewhat exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged 65 years or older.
* Preoperative Mini-Mental State Examination (MMSE) \<27.
* Scheduled to undergo non-cardiac, non-neurosurgical surgery under general anesthesia, with an expected surgical duration \>1 hour.
* Planned hospital stay of at least 1 day before surgery and at least 2 days after surgery.

Exclusion Criteria:

* Communication barriers before surgery due to coma, severe dementia, or language disorders.
* History of schizophrenia, epilepsy, Parkinson's disease, or myasthenia gravis, or delirium before surgery.
* History of brain injury, tumors, or surgery, or intracranial metal implants, or skin or soft tissue injuries on the head or face.
* History of ischemic or hemorrhagic stroke within 3 months before surgery.
* An American Society of Anesthesiologists class ≥ IV.
* Enrolled in other interventional studies.
* Other conditions deemed unsuitable for study participation.

Where it's running

  • Peking University First Hospital
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.